Alyeska Investment Group, L.P. Laboratory Corp Of America Holdings Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $34.9 Million - $42.2 Million	163,788 New	163,788 $37.6 Million
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $7.07 Million - $13.2 Million	-67,762 Reduced 65.66%	35,443 $4.48 Million
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $1.33 Million - $1.41 Million	8,150 Added 8.57%	103,205 $17.5 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $4.37 Million - $4.87 Million	27,367 Added 40.43%	95,055 $16 Million
Q2 2019 Aug 14, 2019	SELL	$144.16 - $172.9 $7.26 Million - $8.71 Million	-50,358 Reduced 42.66%	67,688 $0
Q1 2019 May 15, 2019	SELL	$123.7 - $156.3 $21 Million - $26.5 Million	-169,630 Reduced 58.97%	118,046 $0
Q4 2018 Feb 14, 2019	SELL	$120.82 - $174.09 $17.5 Million - $25.2 Million	-144,613 Reduced 33.45%	287,676 $36.4 Million
Q3 2018 Nov 14, 2018	BUY	$167.67 - $188.27 $72.5 Million - $81.4 Million	432,289 New	432,289 $75.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.